DK137451C - - Google Patents

Info

Publication number
DK137451C
DK137451C DK59571A DK59571A DK137451C DK 137451 C DK137451 C DK 137451C DK 59571 A DK59571 A DK 59571A DK 59571 A DK59571 A DK 59571A DK 137451 C DK137451 C DK 137451C
Authority
DK
Denmark
Application number
DK59571A
Other languages
Danish (da)
Other versions
DK137451B (da
Inventor
J H L M Strubbe
R A Linz
Original Assignee
Ucb(Union Chimique-Chemische Bedrijven) S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb(Union Chimique-Chemische Bedrijven) S.A. filed Critical Ucb(Union Chimique-Chemische Bedrijven) S.A.
Publication of DK137451B publication Critical patent/DK137451B/da
Application granted granted Critical
Publication of DK137451C publication Critical patent/DK137451C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2632-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/272-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK59571AA 1970-02-13 1971-02-10 Analogifremgangsmåde til fremstilling af derivater af 2-oxo-pyrrolidin. DK137451B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB697870A GB1309692A (en) 1970-02-13 1970-02-13 N-substituted lactams

Publications (2)

Publication Number Publication Date
DK137451B DK137451B (da) 1978-03-06
DK137451C true DK137451C (fi) 1978-07-24

Family

ID=9824325

Family Applications (1)

Application Number Title Priority Date Filing Date
DK59571AA DK137451B (da) 1970-02-13 1971-02-10 Analogifremgangsmåde til fremstilling af derivater af 2-oxo-pyrrolidin.

Country Status (15)

Country Link
JP (2) JPS535301B1 (fi)
BE (1) BE762728R (fi)
CH (1) CH530395A (fi)
CS (2) CS167911B2 (fi)
DE (1) DE2106418C2 (fi)
DK (1) DK137451B (fi)
ES (1) ES388135A2 (fi)
FI (1) FI54916C (fi)
FR (1) FR2081508B2 (fi)
GB (1) GB1309692A (fi)
MY (1) MY7400072A (fi)
NL (1) NL168830C (fi)
SU (2) SU508185A3 (fi)
YU (2) YU34876B (fi)
ZA (1) ZA71877B (fi)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1045043B (it) * 1975-08-13 1980-04-21 Isf Spa Derivati pirrolidinici
GB1583871A (en) * 1976-10-19 1981-02-04 Ucb Sa Anti-aggregants
BE864269A (fr) * 1977-03-03 1978-06-16 Parke Davis & Co Nouveaux n-(aminoalkyl substitue)-2-oxo-1-pyrrolidine-acetamides et procedes pour les produire
EP0005689B1 (fr) * 1978-05-08 1981-03-18 U C B, S.A. Nouveaux acides lactame-N-acétiques et leurs amides, leurs procédés de préparation et compositions thérapeutiques
IT1141287B (it) * 1979-06-13 1986-10-01 Nattermann A & Cie Ammidi di acidi pirrolidin-(2)-on-(1)-ilalchil-carbossilici,procedimento per la loro preparazione e prodotti medicinali che le contengono
FR2515179A1 (fr) * 1981-07-24 1983-04-29 Hoffmann La Roche Derives de pyrrolidine, leur procede de preparation, les intermediaires pour leur synthese et leur application therapeutique
EP0089900B1 (en) * 1982-03-24 1985-12-27 Prodes S.A. New n-((2-oxo-1-pyrrolidinyl)acetyl)piperazines, the methods of producing such new compounds and their salts as well as pharmaceutical preparations for therapeutic use containing these compounds or salts
GB8412357D0 (en) * 1984-05-15 1984-06-20 Ucb Sa Pharmaceutical composition
GB8412358D0 (en) * 1984-05-15 1984-06-20 Ucb Sa Pharmaceutical composition
DE3420193A1 (de) * 1984-05-30 1985-12-05 Boehringer Ingelheim KG, 6507 Ingelheim Neue substituierte pyrrolidinone, verfahren zu ihrer herstellung und arzneimittel
US4804400A (en) * 1986-09-12 1989-02-14 Ciba-Geigy Corporation N-phenyl-maleimides and herbicidal and plant growth regulating methods of use thereof
GB8827389D0 (en) * 1988-11-23 1988-12-29 Ucb Sa Process for preparation of(s)alpha-ethyl-2-oxo-1-pyrrolidineacetamide
AR020115A1 (es) * 1998-08-06 2002-04-10 Daiichi Seiyaku Co Agente terapeutico o preventivo para epilepsias rebeldes y uso del compuesto para la produccion de los mismos
GB0004297D0 (en) * 2000-02-23 2000-04-12 Ucb Sa 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses
US6686477B2 (en) 2000-09-29 2004-02-03 Eastman Chemical Company Highly enantiomerically pure lactam-substituted propanoic acid derivatives and methods of making and using same
WO2002094787A1 (en) * 2001-05-23 2002-11-28 Ucb, S.A. 2-oxo-piperidinyl- and 2-oxo-azepanyl alkanoic acid derivativ es for the treatment of epilepsy and other neurological disorders
US7122682B2 (en) 2001-08-10 2006-10-17 Ucb, S.A. Oxopyrrolidine compounds, preparation of said compounds and their use in the manufacturing of levetiracetam and analogues
MXPA04002714A (es) * 2001-10-08 2004-07-05 Ucb Sa Uso de derivados de 2-oxo-1-pirrolidina para el tratamiento de trastornos del movimiento y de la discinesia.
WO2004069796A2 (en) 2003-02-03 2004-08-19 Teva Pharmaceutical Industries Ltd. Process for producing levetiracetam
ES2214147B1 (es) * 2003-02-28 2005-10-01 Farma-Lepori S.A. Procedimiento de obtencion de un agente antiepileptico.
CA2497062A1 (en) 2004-02-18 2005-08-18 Dr. Reddy's Laboratories Limited Preparation of amino acid amides
CA2488325C (en) 2004-11-22 2010-08-24 Apotex Pharmachem Inc. Improved process for the preparation of (s)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide and (r)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide
WO2006095362A1 (en) * 2005-03-10 2006-09-14 Rubamin Limited Process for preparing levetiracetam
US8178533B2 (en) 2005-06-01 2012-05-15 Ucb Pharma, S.A. 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
EP2147911A1 (en) 2008-07-24 2010-01-27 ZaCh System S.p.A. Process for the preparation of levetiracetam
BRPI0920342A2 (pt) 2008-10-16 2020-06-23 The Johns Hopkins University Uso de um inibidor da proteína vesicular sináptica 2a (sv2a) ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica para melhora da função cognitiva, uso de levitiracetam ou um sal farmaceuticamente aceitável do mesmo, uso de brivaracetam ou um sal farmaceuticamente aceitável do mesmo, uso do seletracetam ou um sal farmaceuticamente aceitável do mesmo
US8785661B2 (en) 2009-05-13 2014-07-22 Nektar Therapeutics Oligome-containing pyrrolidine compounds
US7939676B2 (en) 2009-09-17 2011-05-10 Zach System S.P.A. Process for the preparation of levetiracetam
CA2789014C (en) 2010-02-09 2019-01-15 Michela Gallagher Methods and compositions for improving cognitive function
WO2014078568A1 (en) 2012-11-14 2014-05-22 The Johns Hopkins University Methods and compositions for treating schizophrenia
EP3827820A1 (en) 2013-03-15 2021-06-02 The Johns Hopkins University Brivaracetam for improving cognitive function
US11160785B2 (en) 2013-03-15 2021-11-02 Agenebio Inc. Methods and compositions for improving cognitive function
SI3096790T1 (sl) 2014-01-21 2019-11-29 Janssen Pharmaceutica Nv Kombinacije, ki vsebujejo pozitivne aleostrične modulatorje ali ortosterične agoniste metabotropnega glutamatergičnega receptorja podtipa 2 in njihova uporaba
ME03518B (me) 2014-01-21 2020-04-20 Janssen Pharmaceutica Nv Kombinacije koje obuhvataju pozitivne alosterične modulatore ili ortosterične agoniste metabotropnog glutamatergičnog receptora podtipa 2 i njihova primjena
CN104059010A (zh) * 2014-06-12 2014-09-24 浙江华海药业股份有限公司 一种制备2-(2-氧代吡咯烷-1-基)-丁酸酯的方法
CN106591179B (zh) * 2016-12-05 2018-07-03 长兴制药股份有限公司 甲基包囊菌及其在选择性拆分制备(S)-α-乙基-2-氧-1-吡咯烷乙酸盐上的应用
RU2663899C1 (ru) * 2017-07-19 2018-08-13 Федеральное государственное унитарное предприятие "Государственный научный центр "Научно-исследовательский институт органических полупродуктов и красителей" Способ получения 1-карбамоилметил-4-фенил-2-пирролидона
US11384050B1 (en) 2021-02-03 2022-07-12 Vitaworks Ip, Llc Method for preparing levetiracetam and intermediates thereof
US20240132513A1 (en) 2022-08-19 2024-04-25 Agenebio, Inc. Benzazepine derivatives, compositions, and methods for treating cognitive impairment

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1039113A (en) * 1964-08-06 1966-08-17 Ucb Sa New n-substituted lactams

Also Published As

Publication number Publication date
NL7101697A (fi) 1971-08-17
YU34876B (en) 1980-04-30
ES388135A2 (es) 1973-05-01
DK137451B (da) 1978-03-06
FI54916B (fi) 1978-12-29
YU144578A (en) 1982-10-31
FR2081508B2 (fi) 1975-06-06
SU508186A3 (ru) 1976-03-25
SU508185A3 (ru) 1976-03-25
FI54916C (fi) 1979-04-10
ZA71877B (en) 1971-10-27
CS167912B2 (fi) 1976-05-28
CS167911B2 (fi) 1976-05-28
BE762728R (fr) 1971-08-10
DE2106418C2 (de) 1983-12-22
FR2081508A2 (fi) 1971-12-03
MY7400072A (en) 1974-12-31
JPS53130656A (en) 1978-11-14
NL168830B (nl) 1981-12-16
DE2106418A1 (de) 1971-08-19
GB1309692A (en) 1973-03-14
NL168830C (nl) 1982-05-17
JPS5420491B2 (fi) 1979-07-23
JPS535301B1 (fi) 1978-02-25
YU30671A (en) 1979-10-31
CH530395A (fr) 1972-11-15

Similar Documents

Publication Publication Date Title
DK137451C (fi)
AU2044470A (fi)
AU2085370A (fi)
AU2130570A (fi)
AU1716970A (fi)
AU1833270A (fi)
AR195465A1 (fi)
AU1689770A (fi)
AU1789870A (fi)
AU1872870A (fi)
AU1841070A (fi)
AU1881070A (fi)
AU1832970A (fi)
AU2119370A (fi)
AU1969370A (fi)
AU2061170A (fi)
AU1277070A (fi)
AU1879170A (fi)
AU1943370A (fi)
AU1603270A (fi)
AU2112570A (fi)
AU2115870A (fi)
AU1974970A (fi)
AU1918570A (fi)
AU2130770A (fi)

Legal Events

Date Code Title Description
PBP Patent lapsed